Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=61 Randomized Single-blind Other

A Mindfulness-based Intervention for Older Women With Low Sexual Desire

Hypoactive Sexual Desire Disorder · Sexual Dysfunction · Female Sexual Dysfunction

Bottom Line

View on ClinicalTrials.gov: NCT03232801 ↗
Enrolled (actual)
61
Serious AEs
0.0%
Results posted
Oct 2022
Primary outcome: Primary: Feasibility - Number of Enrolled Women Participating in All Sessions — 15; 22 Participants — p=0.027

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
mindfulness-based multicomponent intervention (Behavioral); general health education group (Behavioral)
Age
Adult, Older Adult · 50+ yrs
Sex
Female
Sponsor
University of Pittsburgh
Primary completion
Sep 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Feasibility - Number of Enrolled Women Participating in All Sessions		 15; 22 0.027 sig
PRIMARY
Acceptability - Number of Women Indicating "Somewhat" or "Very Satisfied" on a 5-point Likert Scale Measure of Intervention Satisfaction		 14; 19 0.503
SECONDARY
Change in FSFI Desire Score		 0.4; 0.7 —

Summary

The overall aim of this research is to adapt and pilot test a multi-component, mindfulness-based behavioral intervention for women age 50 and older with low sexual desire.

Eligibility Criteria

Inclusion Criteria

  • meet criteria for a diagnosis of Female Sexual Interest/Arousal Disorder
  • English-speaking
  • have a current sexual partner with whom they are or would like to be sexually active

Exclusion Criteria

  • active major depression
  • active substance abuse
  • current intimate partner violence
  • partner with active major depression
  • partner with active major substance abuse
  • significant relationship dissatisfaction
  • current use of antidepressants
  • untreated dyspareunia (sexual pain)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03232801). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search